BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10859642)

  • 1. Improvement of cystic fibrosis using antitumoral drugs: a hypothesis.
    Faivre L; Bonnefont JP; Lyonnet S; Munnich A; Vekemans M
    Med Hypotheses; 2000 Apr; 54(4):580-1. PubMed ID: 10859642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis?
    Lallemand JY; Stoven V; Annereau JP; Boucher J; Blanquet S; Barthe J; Lenoir G
    Lancet; 1997 Sep; 350(9079):711-2. PubMed ID: 9291908
    [No Abstract]   [Full Text] [Related]  

  • 3. Co-ordinate regulation of the cystic fibrosis and multidrug resistance genes in cystic fibrosis knockout mice.
    Trezise AE; Ratcliff R; Hawkins TE; Evans MJ; Freeman TC; Romano PR; Higgins CF; Colledge WH
    Hum Mol Genet; 1997 Apr; 6(4):527-37. PubMed ID: 9097955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis: recent structural insights.
    Dorwart M; Thibodeau P; Thomas P
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():91-4. PubMed ID: 15463935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of azithromycin on the expression of ATP binding cassette transporters in epithelial cells from the airways of cystic fibrosis patients.
    Cigana C; Nicolis E; Pasetto M; Assael BM; Melotti P
    J Chemother; 2007 Dec; 19(6):643-9. PubMed ID: 18230544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFTR structure and cystic fibrosis.
    Cant N; Pollock N; Ford RC
    Int J Biochem Cell Biol; 2014 Jul; 52():15-25. PubMed ID: 24534272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.
    Riordan JR
    Am J Hum Genet; 1999 Jun; 64(6):1499-504. PubMed ID: 10330337
    [No Abstract]   [Full Text] [Related]  

  • 8. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
    Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
    Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.
    Odolczyk N; Zielenkiewicz P
    Int J Biochem Cell Biol; 2014 Jul; 52():39-46. PubMed ID: 24735712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystic fibrosis: chemical drugs to cure genetic diseases].
    Lallemand JY; Leclaire B; Sermet I; Lenoir G
    Bull Acad Natl Med; 2005 May; 189(5):789-95; discussion 795-6. PubMed ID: 16433451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel missense mutation (Y89C) in exon 3 of the CFTR (ABCC7) gene in a young male.
    Padoan R; Costantini D; Russo MC; Ambrosioni A; Fiori S; Prandoni S; Cantù-Rajnoldi A; Seia M; Giunta A
    Hum Mutat; 2000 May; 15(5):486. PubMed ID: 10790225
    [No Abstract]   [Full Text] [Related]  

  • 12. Membrane-integration characteristics of two ABC transporters, CFTR and P-glycoprotein.
    Enquist K; Fransson M; Boekel C; Bengtsson I; Geiger K; Lang L; Pettersson A; Johansson S; von Heijne G; Nilsson I
    J Mol Biol; 2009 Apr; 387(5):1153-64. PubMed ID: 19236881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial periplasmic permeases as model systems for multidrug resistance (MDR) and the cystic fibrosis transmembrane conductance regulator (CFTR).
    Ames GF
    Soc Gen Physiol Ser; 1993; 48():77-94. PubMed ID: 7684868
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic cystic fibrosis transmembrane regulator 4016insT D1152H compound heterozygosity and male infertility: an Italian case report.
    Rocchetti S; Santonocito C; Concolino P; Torti E; Zuppi C; Giardina B; Capoluongo E
    Clin Chem Lab Med; 2007; 45(7):923-4. PubMed ID: 17617039
    [No Abstract]   [Full Text] [Related]  

  • 16. CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells.
    Mailhot G; Ravid Z; Barchi S; Moreau A; Rabasa-Lhoret R; Levy E
    Am J Physiol Gastrointest Liver Physiol; 2009 Dec; 297(6):G1239-49. PubMed ID: 19808659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modifier genes and cystic fibrosis].
    Corvol H; Flamant C; Vallet C; Clement A; Brouard J
    Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.
    Moran O; Galietta LJ; Zegarra-Moran O
    Cell Mol Life Sci; 2005 Feb; 62(4):446-60. PubMed ID: 15719171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte membrane ATP binding cassette (ABC) proteins: MRP1 and CFTR as well as CD39 (ecto-apyrase) involved in RBC ATP transport and elevated blood plasma ATP of cystic fibrosis.
    Abraham EH; Sterling KM; Kim RJ; Salikhova AY; Huffman HB; Crockett MA; Johnston N; Parker HW; Boyle WE; Hartov A; Demidenko E; Efird J; Kahn J; Grubman SA; Jefferson DM; Robson SC; Thakar JH; Lorico A; Rappa G; Sartorelli AC; Okunieff P
    Blood Cells Mol Dis; 2001; 27(1):165-80. PubMed ID: 11358378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.